Establishment of nucleic acid sensing pathways-based model in predicting response to immunotherapy and targeted drug in hepatitis virus-related hepatocellular carcinoma
机构:[1]Department of Biomedical Engineering, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.四川省人民医院[2]Department of Oncology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.[3]Department of Oncology & Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.四川省人民医院[4]Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.四川省人民医院[5]Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, China.四川省人民医院四川省肿瘤医院
National Natural Science Foundation of China,
Grant/Award Number: 82203539; Excellent
Youth Program Fund of Sichuan Cancer
Hospital, Grant/Award Number: YB2021026;
Department of Science and Technology of
Sichuan Province, Grant/Award Number:
2020YJ0446; Medico‐Engineering
Cooperation Funds from University of
Electronic Science and Technology of China,
Grant/Award Number: ZYGX2021YGCX018;
Science and Technology Bureau of Chengdu
City, Grant/Award Number: 2022‐YF05‐
02119‐SN; Sichuan Science and Technology
Program, Grant/Award Number:
2021YFH0187
第一作者机构:[1]Department of Biomedical Engineering, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.[2]Department of Oncology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
通讯作者:
通讯机构:[1]Department of Biomedical Engineering, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.[3]Department of Oncology & Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.[4]Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.[5]Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, China.[*1]Department of Biomedical Engineering, School of Medicine, University of Electronic Science and Technology of China, No. 4 Section 2, North Jianshe Rd, Chengdu, 610054, Sichuan, China.
推荐引用方式(GB/T 7714):
Peng Xinhao,Shi Ying,Zhang Biqin,et al.Establishment of nucleic acid sensing pathways-based model in predicting response to immunotherapy and targeted drug in hepatitis virus-related hepatocellular carcinoma[J].JOURNAL OF MEDICAL VIROLOGY.2023,95(9):doi:10.1002/jmv.29084.
APA:
Peng Xinhao,Shi Ying,Zhang Biqin,Xu Chuan&Lang Jinyi.(2023).Establishment of nucleic acid sensing pathways-based model in predicting response to immunotherapy and targeted drug in hepatitis virus-related hepatocellular carcinoma.JOURNAL OF MEDICAL VIROLOGY,95,(9)
MLA:
Peng Xinhao,et al."Establishment of nucleic acid sensing pathways-based model in predicting response to immunotherapy and targeted drug in hepatitis virus-related hepatocellular carcinoma".JOURNAL OF MEDICAL VIROLOGY 95..9(2023)